Exhibit 23.1

            Consent of Independent Registered Public Accounting Firm

We consent to the references to our firm under the captions "Summary Financial
Data," "Selected Financial Data" and "Experts" and to the use of our report
dated March 8, 2004 (except for Note 12 as to which the date is August 4, 2004
and except for the sixth paragraph of Note 1, as to which the date is October
13, 2004) in Amendment No. 2 to the Registration Statement (Form S-1 No.
333-118012) and related Prospectus of Adeza Biomedical Corporation for the
registration of 4,312,500 shares of its common stock.

                                   Ernst & Young LLP



Palo Alto, California



The foregoing consent is in the form that will be signed upon the completion of
the reverse stock split described in the sixth paragraph of Note 1 to the
financial statements.

                                   /s/ Ernst and Young LLP



Palo Alto, California
October 26, 2004